Skip to main content

Table 2 List of treatments and immunization does

From: In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice

 T1T2T3T4T5T6T7T7T9T10T11T12T13
TreatmentsOMP31IL-23EOMP-IL2OMP+IL23E-IL23E+IL2OMP-IL2+ IFAOMP+ IFARev1LPSaIFAPBS
Dose of injection30μg30μg30μg30μg30μg+30μg30μg30μg+30μg30μg30μg1dose100μl100μl100μl
  1. aThis treatment contains an extract of the periplasmic part of the BL21 (DE3) bacterium which may contains bacterial lipopolysaccharide (LPS)
\